January 8, 2025
Researchers at UC San Diego School of Medicine are serving as the central data hub for the CHARM Network, a new five-year pandemic preparedness initiative funded by the CDC. This includes ensuring real-time public access to results on the incidence of the most common respiratory infections.
April 3, 2020
Heat waves driven by Santa Ana winds can cause perceptible impacts on hospitalizations for kidney failure, dehydration, and respiratory disease in fall, spring, and winter according to a team of San Diego scientists.
December 14, 2020
Temperature data collected by wearable devices worn on the finger can be reliably used to detect the onset of fevers, a leading symptom of both COVID-19 and the flu, according to a team of researchers from the University of California San Diego, UC San Francisco and MIT Lincoln Lab.
November 1, 2019
San Diego-based Predictive Science, Inc. this week released their first forecast for the 2019-2020 influenza season, which typically runs from November through March.
July 12, 2023
UC San Diego scientists contest longstanding hypothesis about mysterious illness affecting Gulf War veterans, providing first direct evidence that symptoms are driven by impaired mitochondria.
January 24, 2013
…or prevents severe influenza illness. The sooner you get the vaccine, the better because it takes two weeks for your immunity to develop.” UC San Diego’s Student Health Services has administered about 3,000 flu vaccines during the 2012/2013 academic year, according to Dr. Regina Fleming-Magit, director of Student Health Services.…
June 17, 2022
UC San Diego researchers report significant decrease in national cases of Kawasaki disease during COVID-19 pandemic; findings hint at origins of disease.
November 12, 2019
National attention has been drawn to the plight of patients who have experienced the unintended side effects of prolonged ICU care such as memory loss and muscle weakness. Now, a research team led by UC San Diego have evaluated the employment impacts to ICU patients, with concerning findings.
April 27, 2020
Researchers at UC San Diego Health report in newly published findings that olfactory impairment suggests the resulting COVID-19 disease is more likely to be mild to moderate, a potential early indicator that could help health care providers determine which patients may require hospitalization.
August 15, 2012
An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The study will appear in the August 16, 2012 issue of the New…
